Skip to content
SupplementMagazine

Minerals

Calcium Supplements: In the 4 Best Trials, No Effect on Any Fracture

By Emrah Sümer, Founder & Managing Editor
August 13, 2026
Two specimens of the upper end of a human femur on a dark surface, one cut vertically to show the spongy internal bone structure, with a coin for scale
Two specimens of the upper end of a human femur on a dark surface, one cut vertically to show the spongy internal bone structure, with a coin for scalePhotograph MAKY.OREL, CC0, via Wikimedia Commons

Key takeaways

  • Across 20 studies (n=58,573), calcium supplements cut total fracture risk: RR 0.89 (95% CI 0.81-0.96). Roughly an 11% relative reduction.
  • But in the four randomised trials at lowest risk of bias (n=44,505), there was no effect on fracture at any site.
  • No reduction in hip or forearm fractures in any analysis, which are the fractures that matter most.
  • Dietary calcium intake was not associated with fracture risk, and no trial evidence shows that raising dietary calcium prevents fractures.
  • Bone density gains are real but tiny and non-progressive: about 0.7 to 1.8%, arriving once rather than accumulating.
  • The authors' own verdict: evidence that calcium supplements prevent fractures is weak and inconsistent.

Two systematic reviews. Same journal, same year, same research group, one covering fractures and one covering bone density. Together they take apart the reason most people take calcium.

The number the supplement aisle would quote

Across 20 studies and 58,573 people, calcium supplements reduced total fracture risk:

RR 0.89 (95% CI 0.81 to 0.96) — about an 11% relative reduction, and the interval clears 1.

Vertebral fractures too: RR 0.86 (95% CI 0.74 to 1.00), 12 studies, 48,967 people.

Stop reading there and calcium looks like a modest success.

The sentence that comes next

In randomised controlled trials at lowest risk of bias (four studies, n=44,505), there was no effect on risk of fracture at any site.

Not a smaller effect. No effect. At any site.

And note the sample: 44,505 people. This is not a case of the good trials being too small to detect something. The null result there is a finding, not a shrug.

Which studies you countResult
All 20 studies (n=58,573)RR 0.89 — reduction
The 4 at lowest risk of bias (n=44,505)No effect at any site

When an effect shrinks as study quality rises, the usual explanation is that some of it was a property of the study designs rather than of the treatment.

And it was never the fracture that matters most

Even in the generous pooled analysis, the reduction covered total and vertebral fractures — and not hip or forearm.

Hip fracture is the outcome with the most serious consequences for independence and survival in older people. It is the fracture most people are actually thinking about when they buy calcium.

It did not move.

Why: the density gain is about one percent, and it happens once

The companion review measured what calcium does to bone mineral density, and the finding explains everything above.

1 year2 yearsOver 2.5 years
Supplements, all five skeletal sites0.7–1.8%0.7–1.8%0.7–1.8%

Read that row across. More years on the tablets did not produce more bone.

The authors’ word for it is non-progressive:

increasing calcium intake from dietary sources or by taking calcium supplements produces small non-progressive increases in BMD, which are unlikely to lead to a clinically significant reduction in risk of fracture

A one-off gain of roughly one percent is not the kind of change that would be expected to shift fracture rates. So when the best trials went looking for a fracture effect and found none, that was consistent rather than surprising.

”Then I’ll get it from food”

This is the standard fallback, and here the evidence is weaker, not stronger.

Dietary calcium intake is not associated with risk of fracture, and there is no clinical trial evidence that increasing calcium intake from dietary sources prevents fractures.

Most dietary studies showed no fracture association at all. Food is a fine way to get calcium; it is not a demonstrated way to prevent a fracture.

What this page is not saying

Three limits, stated because they genuinely apply:

  • Not about diagnosed osteoporosis treatment. Calcium is often given alongside prescription bone drugs whose own trials ran with calcium in the background. That is a different question from a healthy adult supplementing to prevent a future problem.
  • Not about diagnosed deficiency. Hypocalcaemia, malabsorption and unusually low baseline intake are outside these reviews.
  • Not a safety claim. Nothing here is about harm. It is about whether the intended benefit occurs.

No product box

There is no buy button here, and the reason is the whole article: the supplement’s fracture benefit does not survive the best-designed trials, and the food alternative has less evidence rather than more.

That leaves nothing honest to point at. Where the evidence does support a specific purchase, we say so — which is what makes it worth something when we do.

Frequently asked questions

Do calcium supplements prevent fractures?

The honest answer is that it depends which studies you count, and that dependency is itself the finding. Pooling everything, calcium supplements reduced total fracture risk across 20 studies covering 58,573 people, with a relative risk of 0.89 and a 95% confidence interval of 0.81 to 0.96, and reduced vertebral fracture across 12 studies covering 48,967 people, RR 0.86, 95% CI 0.74 to 1.00. Restricting to the randomised controlled trials at lowest risk of bias, four studies covering 44,505 people, there was no effect on risk of fracture at any site. The review's own conclusion is that evidence that calcium supplements prevent fractures is weak and inconsistent.

Why does restricting to the best trials matter so much?

Because when an effect shrinks as study quality rises, the most likely explanation is that the effect was partly an artefact of the weaker designs rather than a property of the treatment. This is one of the cleanest examples available: 44,505 people in the low-bias trials is not a small or underpowered sample, so the null result there is not a failure to detect something. It is a finding in its own right. Any summary of calcium that quotes the 0.89 without the low-bias analysis is quoting the half of the evidence that flatters the supplement.

What about hip fractures specifically?

No reduction, in any analysis. The review reports the reduction in total and vertebral fracture but states it did not extend to hip or forearm fractures. This matters more than the headline number, because hip fracture is the outcome with the most serious consequences for independence and mortality in older people, and it is the outcome most people have in mind when they take calcium for their bones. The reduction that was found sat in categories that do not include it.

Does getting calcium from food work better?

The review examined that separately and found less, not more. For dietary calcium, most studies showed no fracture associations, and the conclusion is explicit: dietary calcium intake is not associated with risk of fracture, and there is no clinical trial evidence that increasing calcium intake from dietary sources prevents fractures. This is worth stating plainly because the common fallback when supplements disappoint is that food would have worked. Here, the food route has less evidence behind it rather than more.

But calcium does increase bone density, doesn't it?

Yes, and the size is the point. The companion review found that increasing calcium intake from dietary sources increased bone mineral density by 0.6 to 1.0% at the total hip and total body at one year, and by 0.7 to 1.8% at those sites plus the lumbar spine and femoral neck at two years, while calcium supplements produced increases of 0.7 to 1.8% at all five skeletal sites at one year, two years, and over two and a half years. The authors' conclusion is that increasing calcium intake produces small non-progressive increases in BMD which are unlikely to lead to a clinically significant reduction in risk of fracture.

What does non-progressive mean here?

It means the gain happens once and then stops, rather than accumulating with continued use. Look at the supplement figures: 0.7 to 1.8% at one year, and the same 0.7 to 1.8% at over two and a half years. More time on the tablets did not produce more density. That is the mechanistic explanation for the fracture results, and it is the detail that makes the whole picture cohere: a one-off shift of about one percent is not the kind of change that would be expected to move fracture rates, and when the best trials looked for a fracture effect they did not find one.

Should I stop taking calcium?

This page cannot make that decision, and there is a specific reason to be careful rather than sweeping. Some people take calcium as part of a treatment plan for diagnosed osteoporosis, often alongside prescription drugs whose own trials were conducted with calcium supplementation in the background, and that is a different situation from a healthy adult taking calcium to prevent a future problem. What the evidence here addresses is the second case. If you are taking calcium on your own initiative to prevent fractures, the two reviews on this page are the best available answer to whether that works, and the answer is weak and inconsistent. If it was prescribed as part of managing a diagnosed condition, that is a conversation with the person who prescribed it.

Why is there no product recommendation on this page?

Because the conclusion does not support one, and because the alternative usually offered does not either. Where an article here concludes that something specific and purchasable follows from the evidence, we link it. This one concludes that the supplement's fracture benefit disappears in the best-designed trials, and that dietary calcium has even less evidence behind it, which leaves nothing to point at. A site that puts a buy button under every article has told you the buttons mean nothing.

Sources

Every claim above is drawn from these primary sources. Last checked July 2026.

  1. 1.Bolland MJ, Leung W, Tai V, Bastin S, Gamble GD, Grey A, Reid IR. Calcium intake and risk of fracture: systematic review. BMJ. 2015;351:h4580. PMID 26420387. For dietary calcium, most studies showed no fracture associations. Calcium supplements reduced total fracture risk (20 studies, n=58,573; RR 0.89, 95% CI 0.81 to 0.96) and vertebral fracture (12 studies, n=48,967; RR 0.86, 95% CI 0.74 to 1.00) but not hip or forearm fractures. Verbatim: 'In randomised controlled trials at lowest risk of bias (four studies, n=44,505), there was no effect on risk of fracture at any site.' Authors' conclusions verbatim: 'Dietary calcium intake is not associated with risk of fracture, and there is no clinical trial evidence that increasing calcium intake from dietary sources prevents fractures. Evidence that calcium supplements prevent fractures is weak and inconsistent.' Checked 13 August 2026
  2. 2.Tai V, Leung W, Grey A, Reid IR, Bolland MJ. Calcium intake and bone mineral density: systematic review and meta-analysis. BMJ. 2015;351:h4183. PMID 26420598. Increasing calcium intake from dietary sources increased bone mineral density by 0.6-1.0% at the total hip and total body at one year and by 0.7-1.8% at these sites and the lumbar spine and femoral neck at two years. Calcium supplements showed increases of 0.7-1.8% at all five skeletal sites at one, two, and over two and a half years. No forearm effect was observed. Authors' conclusion verbatim: 'Increasing calcium intake from dietary sources or by taking calcium supplements produces small non-progressive increases in BMD, which are unlikely to lead to a clinically significant reduction in risk of fracture.' Checked 13 August 2026
  3. 3.Note on scope, recorded because it limits what this page can claim. Both reviews above address calcium intake in relation to bone mineral density and fracture risk in the general adult population. They do not address calcium supplementation given as part of a treatment regimen for diagnosed osteoporosis alongside prescription bone drugs, they do not address calcium given for diagnosed hypocalcaemia or malabsorption, and they do not address populations with unusually low baseline intake. Nothing on this page should be read as applying to those situations. Checked 13 August 2026